Austrianova discovers new therapeutic for cancer gene therapy
Date: 1.3.2006
The Viennese biotech company, Austrianova, together with its partner at the Research Institute for Virology and Biomedicine, University of Veterinary Medicine have shown that a gene from a bacteriophage (a virus infecting bacteria), can be used for the treatment of cancer.
The Department of Therapeutic Genes & Delivery Systems at Austrianova, headed by Dr. Christine Hohenadl, have shown for the first time that a bacteriophage protein, called holin, can destroy human breast cancer cells. This discovery could form the basis for a new treatment of solid tumours and has been published in the international peer reviewed scientific publication “Journal of Gene Medicine” .
"Source":[ http://www.austrianova.com/Pa_AN_Holin_010206_english.doc].
Related articles
Gene therapy for foetuses hope - The work is controversial not just because of the ethics but also safety concerns (20.3.2007)
DNA nanoparticles hold promise in gene therapy for Parkinson's disease - University of Kentucky researcher David Yurek was recently awarded $66,000 by The Michael J (3.3.2007)
